Recessive Symptomatic Focal Epilepsy and Mutant Contactin-Associated Protein-like 2
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Contactin-associated protein-like 2 (CASPR2) is encoded by CNTNAP2 and clusters voltage-gated potassium channels (K(v)1.1) at the nodes of Ranvier. We report a homozygous mutation of CNTNAP2 in Old Order Amish children with cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes. Intractable focal seizures began in early childhood, after which language regression, hyperactivity, impulsive and aggressive behavior, and mental retardation developed in all children. Resective surgery did not prevent the recurrence of seizures. Temporal-lobe specimens showed evidence of abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of CASPR2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this neurodevelopmental phase, Caspr2, the protein encoded by CNTNAP2, is thought to assist in interactions important for cellular migration and subsequent laminar organization, indicating a role for CNTNAP2 in the construction of neural circuits (Strauss et al. 2006).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Strauss et al. 2006
In the citing paper
“Furthermore, temporal lobe sections from human subjects lacking Cntnap2 display abnormal patterns of neuronal migration (Strauss et al., 2006).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Strauss et al., 2006
In the citing paper
“In the syndromic cases where genetic information was assessed, cases were rarely separated based on presence or absence of ASD or only qualitative neuropathology was provided [128, 340].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [340]
Citations
Cites
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Kindling and status epilepticus models of epilepsy: rewiring the brain
Morimoto, K., Fahnestock, M., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 838
An astrocytic basis of epilepsy
Tian, G.-F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H. R., et al. (2005) · Nature Medicine · doi:10.1038/nm1277 · Cited by 806
The local differentiation of myelinated axons at nodes of Ranvier
Poliak, S., & Peles, E. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1253 · Cited by 625
Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice
Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., & Tempel, B. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81018-1 · Cited by 599
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C. L., Xu, X., Chiu, S.-Y., Shrager, P., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305018 · Cited by 564
(2000) · Elsevier eBooks · doi:10.1016/b978-0-12-065310-2.x5000-0 · Cited by 472
Zuberi, S. M. (1999) · Brain · doi:10.1093/brain/122.5.817 · Cited by 366
T HE B IOLOGY OF E PILEPSY G ENES
Noebels, J. L. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081210 · Cited by 296
Clinical disorders of brain plasticity
Johnston, M. V. (2004) · Brain and Development · doi:10.1016/s0387-7604(03)00102-5 · Cited by 274
Cited by
Items 301–400 of 657
Modeling of Autism Genetic Variations in Mice: Focusing on Synaptic and Microcircuit Dysfunctions
Qiu, S., Aldinger, K. A., & Levitt, P. R. (2012) · Developmental Neuroscience · doi:10.1159/000336644 · Cited by 33
Wang, H. B., Tahara, Y., Luk, S. H. C., Kim, Y.-S., Hitchcock, O. N., Kaswan, Z. A. M., Kim, Y. I., Block, G. D., Ghiani, C. A., Loh, D. H., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105064 · Cited by 40
“associated with ASD, intellectual disabilities, and seizures in patients (Arking et al., 2008; Bakkaloglu et al., 2008; Nord et al., 2011; O'Roak et al., 2011; Strauss et al., 2006) as well as in”
Momoi, T., Fujita, E., Senoo, H., & Momoi, M. Y. (2010) · Cell Biology International · doi:10.1042/cbi20090250 · Cited by 34
“and suggested a role for CNTNAP2 in idiopathic autism (Strauss et al., 2006).”
BackgroundWincent, J., Anderlid, B.-M., Lagerberg, M., Nordenskjöld, M., & Schoumans, J. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01442.x · Cited by 32
“CNTNAP2 has been associated with epilepsy, schizophrenia (22) and autism spectrum disorder (23), but a translocation disrupting the gene has been described in a healthy family (24) and pathogenic homozygous point mutations have been identified (25).”
BackgroundStructural MRI biomarkers of shared pathogenesis in autism spectrum disorder and epilepsy
Blackmon, K. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.02.017 · Cited by 35
Linkage and linkage disequilibrium scan for autism loci in an extended pedigree from Finland
Kilpinen, H., Ylisaukko‐oja, T., Rehnström, K., Gaál, E. I., Turunen, J. A., Kempas, E., von Wendt, L., Varilo, T., & Peltonen, L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp229 · Cited by 35
Dissection of genetic associations with language-related traits in population-based cohorts
Paracchini, S. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9091-6 · Cited by 40
“However, consistent replications in independent samples at the same locus and often with the same genetic markers provide robust support to these associations.”
BackgroundUddén, J., Snijders, T. M., Fisher, S. E., & Peter Hagoort, A. (2016) · Brain and Language · doi:10.1016/j.bandl.2016.02.003 · Cited by 32
“All rights reserved.”
Oron, O., & Elliott, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040828 · Cited by 33
“Cortical Dysplasia-focal Epilepsy (CDFE) syndrome is caused by mutations in Contactin Associated Protein 2 (CNTNAP2), where a subgroup of patients express autistic behavior [11].”
BackgroundMöhrle, D., Wang, W., Whitehead, S. N., & Schmid, S. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.710593 · Cited by 33
Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration
Fukuda, T., & Yanagi, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2539-4 · Cited by 31
“Cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes have been observed in patients with a homozygous mutation of the CNTNAP2 gene [156].”
Maintenance of neuronal polarity
Ho, T. S., & Rasband, M. N. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20843 · Cited by 35
“Intriguingly, mutations in Caspr2 have been linked to autism spectrum disorder, epilepsy, and mental retardation (Strauss et al., 2006; Bakkaloglu et al., 2008; Zweier et al., 2009).”
BackgroundRegulatory Mechanisms Controlling Maturation of Serotonin Neuron Identity and Function
Spencer, W. C., & Deneris, E. S. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00215 · Cited by 31
“…have been associated with Autism spectrum disorder, in particular CNTNAP2, although another report has associated a mutation in CNTNAP3 with Asperger’s syndrome (Strauss et al., 2006; Alarcón et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008; Peñagarikano et al., 2011; Vaags et al., 2012).”
BackgroundAmbient Experience in Restitutive Treatment of Aphasia
McClung, J. S., Rothi, L. J. G., & Nadeau, S. E. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00183 · Cited by 32
Kaya, N., Alsagob, M., D’Adamo, M. C., AlBakheet, A., Hasan, S., Muccioli, M., Almutairi, F. B., Almass, R., Aldosary, M. S., Monies, D., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103637 · Cited by 31
Toward the Language Oscillogenome
Murphy, E., & Benítez‐Burraco, A. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01999 · Cited by 32
An oscillopathic approach to developmental dyslexia: From genes to speech processing
Jiménez-Bravo, M., Aguiar, V. M., & Benítez‐Burraco, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.048 · Cited by 31
Beňová, B., & Jacques, T. S. (2018) · Brain Pathology · doi:10.1111/bpa.12686 · Cited by 29
“Strauss et al (63) published an interesting report of homozygous mutation of CNTNAP2 in two Old Order Amish siblings with focal epilepsy and cortical dysplasia undergoing epilepsy surgery.”
BackgroundGeorge-Hyslop, F. S., Kivisild, T., & Livesey, F. J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1017144 · Cited by 30
“Post-mortem brain analyses of CNTNAP2 patients with CDFE have identified neurons in the temporal cortex with irregularly oriented dendritic processes (Strauss et al., 2006).”
BackgroundInfluentialThe role of rare structural variants in the genetics of autism spectrum disorders
Kusenda, M., & Sebat, J. L. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184690 · Cited by 34
The association of CNTNAP2 rs7794745 gene polymorphism and autism in Iranian population
Zare, S., Mashayekhi, F., & Bidabadi, E. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.01.008 · Cited by 31
Rodenas-Cuadrado, P., Mengede, J., Baas, L., Devanna, P., Schmid, T. A., Yartsev, M. M., Firzlaff, U., & Vernes, S. C. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24385 · Cited by 31
“…in CNTNAP2 can produce a range of phenotypes in addition to speech and language problems including autistic phenotypes, intellectual disability, and epilepsy (Strauss et al., 2006; Alarc on et al., 2008; Bakkaloglu et al., 2008; Rodenas-Cuadrado et al., 2014; Rodenas-Cuadrado et al., 2016).”
BackgroundStephan, D. A. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.003 · Cited by 31
Self-citationInsights into the Genetic Foundations of Human Communication
Graham, S. A., Deriziotis, P., & Fisher, S. E. (2015) · Neuropsychology Review · doi:10.1007/s11065-014-9277-2 · Cited by 29
Chien, Y., Chen, Y., & Gau, S. S. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102729 · Cited by 29
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date
Fung, L. K., & Hardan, A. Y. (2015) · CNS Drugs · doi:10.1007/s40263-015-0252-0 · Cited by 29
“CNTNAP2 has been found to be associated with language development delays in children with ASD [33–36].”
BackgroundEtiological Heterogeneity in Autism Spectrum Disorders
Betancur, C., & Coleman, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00008-9 · Cited by 29
“… (10 individuals reported) CNTNAP2 (7q35); recessive Mutation Extremely rare 67% (6/9) autism or ASD Severe intractable seizures, ID, ASD, and focal brain malformations in Amish children (Strauss et al., 2006) Brain creatine transporter deficiency…”
Immunity and ultrasonic vocalization in rodents
Jouda, J., Wöhr, M., & del Rey, A. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13931 · Cited by 29
Recent Advances in the Genetics of Vocal Learning
Condro, M. C., & White, S. A. (2014) · Comparative Cognition & Behavior Reviews · doi:10.3819/ccbr.2014.90003 · Cited by 27
“To further investigate the relationship between 7Recent Advances in the Genetics of Vocal Learning domains of the protein (Figure 2, Strauss et al., 2006).”
BackgroundInfluentialLandi, N., & Perdue, M. V. (2019) · Language and Linguistics Compass · doi:10.1111/lnc3.12349 · Cited by 29
“4.1.2 | CNTNAP2 CNTNAP2 has been identified as a risk-gene for DLD and autism (Alarcón et al., 2008; Strauss et al., 2006), and variation in CNTNAP2 has been associated with performance on nonsense word repetition (Vernes et al., 2008) and with rapid auditory processing (Riva et al., 2018).”
InfluentialAddis, L., Friederici, A. D., Kotz, S. A., Sabisch, B., Barry, J., Richter, N., Ludwig, A. A., Rübsamen, R., Albert, F. W., Pääbo, S., et al. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00583.x · Cited by 27
“Another gene in the contactin family, CNTNAP2, is found to be mutated in the Amish population causing a rare neuronal migration disorder, cortical dysplasiafocal epilepsy (CDFE), resulting in language delay, seizures and autism (Strauss et al. 2006).”
Irani, S. R., & Vincent, A. C. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000400015 · Cited by 28
Intercellular signaling by ectodomain shedding at the synapse
Martin‐de‐Saavedra, M. D., Santos, M. D., & Penzes, P. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.03.004 · Cited by 28
O’Toole, O., & Quek, A. M. L. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1660860 · Cited by 28
Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease
Tábuas‐Pereira, M., Santana, I. J., Guerreiro, R. J., & Brás, J. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00182-y · Cited by 29
Ben‐Reuven, L., & Reiner, O. (2016) · Development Growth & Differentiation · doi:10.1111/dgd.12280 · Cited by 27
“A homozygous mutation of another member of this family, Contactin associated protein-2 (CNTNAP2 or Caspr2), involved in neuron–glia interactions and clustering of K+ channels in myelinated axons, was identified in PDD and language delayed children (Strauss et al. 2006).”
BackgroundBrain Organoids and Assembloids—From Disease Modeling to Drug Discovery
Ajongbolo, A. O., & Langhans, S. A. (2025) · Cells · doi:10.3390/cells14110842 · Cited by 29
“Homozygous mutations leading to the loss of function in CNTNAP2 are linked to cortical dysplasia focal epilepsy syndrome, which includes features of autism spectrum disorder (ASD) and intellectual disability [180].”
Dawson, M. S., Gordon-Fleet, K., Yan, L., Tardos, V., He, H., Mui, K., Nawani, S., Asgarian, Z., Catani, M., Fernandes, C., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05215-0 · Cited by 29
Crespi, B. J. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_8 · Cited by 27
“The existence and structure of brain-specific imprinted-gene network should have important implications for pharmacological interventions; for example, of the 11 genes most-highly altered in expression from treatment of mice with the mood-stabilizer drug valproic acid (Chetcuti et al. 2006), two are imprinted (Peg3 an…”
BackgroundCommon Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders
Rodriguez, R. A., Joya, C., & Hines, R. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00132 · Cited by 35
“Genetic analysis of CNTNAP2 in ASD has revealed deletions producing a frameshift mutations leading to early introduction of a stop codon (Strauss et al., 2006; Watson et al., 2014).”
BackgroundUnravelling neurogenetic networks implicated in developmental language disorders
Vernes, S. C., & Fisher, S. E. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371263 · Cited by 25
Effects of Amyloid-β Plaque Proximity on the Axon Initial Segment of Pyramidal Cells
León‐Espinosa, G., DeFelipe, J., & Muñoz, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112036 · Cited by 28
The CNTNAP2-CASK complex modulates GluA1 subcellular distribution in interneurons
Gao, R., Zaccard, C. R., Shapiro, L. P., Dionisio, L. E., Martin‐de‐Saavedra, M. D., Piguel, N. H., Pratt, C. P., Horan, K. E., & Penzes, P. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.025 · Cited by 25
“Genetic variation in the CNTNAP2 gene, including copy number variations, exon deletions, truncations, single nucleotide variants, and polymorphisms have been associated with autism spectrum disorder, schizophrenia, intellectual disability, epilepsy, and language disorders[1,8,11,32,40,43].”
BackgroundNew therapeutic options for autism spectrum disorder: experimental evidences
Peñagarikano, O. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.301 · Cited by 24
“The Cntnap2 knockout mouse model of ASD, a gene involved in a syndromic form of ASD called Cortical Dysplasia and Focal Epilepsy syndrome [85] also shows lower OXT levels in brain, and both exogenous administration and activation of endogenous OXT release restored social behavior in this model [86].”
BackgroundRecent Advances in the Pathogenesis of Syndromic Autisms
Benvenuto, A., Manzi, B., Alessandrelli, R., Galasso, C., & Curatolo, P. (2009) · International Journal of Pediatrics · doi:10.1155/2009/198736 · Cited by 25
The enteric nervous system deficits in autism spectrum disorder
Wang, X., Tang, R., Wei, Z., Zhan, Y., Lu, J., & Li, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1101071 · Cited by 26
Marchese, M., Valvo, G., Moro, F., Sicca, F., & Santorelli, F. M. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8378-2 · Cited by 24
“CNTNAP2 (contactin-associated protein-like 2), which encodes a member of the neurexin superfamily, has a well-established role in ASD and epilepsy (Strauss et al. 2006; Bakkaloglu et al. 2008).”
Molecular biology of epilepsy genes
Williams, C. A., & Battaglia, A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.001 · Cited by 25
“Mutations in CNTNAP2 (Neurexin IV) disrupt a protein that is a member of the Neurexin super family and cause the cortical dysplasia focal epilepsy syndrome (CDFE) (Strauss et al., 2006).”
BackgroundClair, D. S., & Johnstone, M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0037 · Cited by 24
“Among these genes are NGLN4X [14], SHANK3 [23,24], NRXN1 [25,26], SHANK2 [27], CNTN4 [28–30] and CNTNAP2 [31,32].”
Tzimourakas, A., Giasemi, S., Mouratidou, M. C., & Karagogeos, D. (2007) · Biotechnology Journal · doi:10.1002/biot.200700023 · Cited by 24
Nebel, R. A., Kirschen, J., Cai, J., Woo, Y. J., Cherian, K. A., & Abrahams, B. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129270 · Cited by 27
“Rare mutations in other autism related genes such as CNTNAP2 and CHD8 are also associated with both autism and macrocephaly [22,23],while mutations in the risk genes AUTS2 and DHCR7 give rise to autism and microcephaly [24–26].”
BackgroundAn emerging map of glutamate delta 1 receptors in the forebrain
Andrews, P. C., & Dravid, S. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108587 · Cited by 25
D’Onofrio, G., Accogli, A., Severino, M., Caliskan, H., Kokotović, T., Blažeković, A., Gotovac, K., Markovic, S., Žigman, T., Goran, K., et al. (2023) · Human Genetics · doi:10.1007/s00439-023-02552-2 · Cited by 25
“Similarly, ASD ( p = 0.009), hyporeflexia ( p = 0.012), language impairment ( p = 0.020), as well as a moderate to severe degree of ID ( p = 0.031) were more frequent in patients with biallelic variants.”
BackgroundMethodResultInfluentialStrauss, K. A., Puffenberger, E. G., Bunin, N., Rider, N. L., Morton, M. C., Eastman, J. T., & Morton, D. H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.02.016 · Cited by 23
Self-citationGenetics of Pediatric Epilepsy: Next-Generation Sequencing in Clinical Practice
Blažeković, A., Gotovac, K., Meglaj, S., Đuranović, V., Prpić, I., Lozić, B., Malenica, M., Markovic, S., Lujić, L., Gadže, Ž. P., et al. (2022) · Genes · doi:10.3390/genes13081466 · Cited by 26
“( CNTNAP2 , ABCB1 , ADGRV1 , STXBP1 , EFHC1 , and PRRT2 ) (Figure 4).”
Ahmed, N. Y., Knowles, R., Liu, L., Yan, Y., Li, X., Schümann, U., Wang, Y., Sontani, Y., Reynolds, N., Natoli, R., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1112062 · Cited by 23
“The ASD risk gene Contactinassociated protein-like 2 (Cntnap2/CASPR2), first shown to be altered in patients presenting with severe autism features (Strauss et al., 2006), is a transmembrane scaffolding protein and a cell adhesion protein of the neurexin family which coordinates several processes that are critical for…”
BackgroundHaddad, F. L., Oliveira, C. D., & Schmid, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1160243 · Cited by 23
“A homozygous loss-of-function mutation in the human CNTNAP2 leads to a syndromic form of ASD, with the syndrome also including cortical dysplasia, seizures, language regression, and cognitive delays (Strauss et al., 2006; Jackman et al., 2009; Zweier, 2011; Peñagarikano and Geschwind, 2012; Rodenas-Cuadrado et al., 20…”
BackgroundNeuroanatomical Alterations in the CNTNAP2 Mouse Model of Autism Spectrum Disorder
Gandhi, T., Canepa, C. R., Adeyelu, T. T., Adeniyi, P. A., & Lee, C. C. (2023) · Brain Sciences · doi:10.3390/brainsci13060891 · Cited by 25
“Mutant mice also demonstrate defects in cortical neuronal migration, reduced cortical interneuron number, abnormal cortical network activity, and ectopic neurons in the corpus callosum [30], and corresponds with MRI brain scans and histological analysis of resected brain tissues from human patients with CDFE syndrome…”
BackgroundA homozygous SLITRK6 nonsense mutation is associated with progressive auditory neuropathy in humans
Morlet, T. G., Rabinowitz, M., Looney, L. R., Riegner, T., Greenwood, L. A., Sherman, E. A., Achilly, N. P., Zhu, A., Yoo, E. S., O’Reilly, R., et al. (2013) · The Laryngoscope · doi:10.1002/lary.24361 · Cited by 22
Self-citationMaternal Antibody and ASD: Clinical Data and Animal Models
Gata-Garcia, A., & Diamond, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01129 · Cited by 24
Focal cortical dysplasia is more common in boys than in girls
Ortiz-Gonzalez, X. R., Poduri, A., Roberts, C. M., Sullivan, J. E., Marsh, E. D., & Porter, B. E. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.12.035 · Cited by 22
“In most patients, the specific molecular etiology of FCD is not identifiable, with only rare cases having a strong genetic basis [8].”
Altered Cerebellar Response to Somatosensory Stimuli in the Cntnap2 Mouse Model of Autism
Fernández, M. C., Sánchez-León, C. A., Llorente, J., Sierra-Arregui, T., Knafo, S., Márquez‐Ruiz, J., & Peñagarikano, O. (2021) · eNeuro · doi:10.1523/eneuro.0333-21.2021 · Cited by 24
“patients harboring CNTNAP2 mutations (Strauss et al., 2006).”
BackgroundMöhrle, D., Yuen, M., Zheng, A., Haddad, F. L., Allman, B. L., & Schmid, S. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12841 · Cited by 21
Al-Murrani, A., Ashton, F., Aftimos, S. F., George, A. M., & Love, D. R. (2012) · Case Reports in Genetics · doi:10.1155/2012/172408 · Cited by 23
Fakhoury, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.026 · Cited by 25
“During development, Caspr2 participates in intercellular interactions that are important for neuroblast migration and laminar organization, suggesting a role for the CNTNAP2 gene in neural circuit assembly (Strauss et al., 2006).”
BackgroundLi, X., Han, X., Tu, X., Zhu, D., Feng, Y., Jiang, T., Yang, Y.-P., Qu, J., & Chen, J.-G. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy185 · Cited by 21
Severe Intellectual Disability Associated with Recessive Defects in CNTNAP2 and NRXN1
Zweier, C. (2011) · Molecular Syndromology · doi:10.1159/000331270 · Cited by 26
“Behavioral anomalies with autistic traits or pervasive developmental delay, stereotypic movements and attention deficit-hyperactivity disorder are common [Strauss et al., 2006; Jackman et al., 2009; Zweier et al., 2009].”
BackgroundInfluentialWerling, A. M., Bobrowski, E., Taurines, R., Gundelfinger, R., Romanos, M., Grünblatt, E., & Walitza, S. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1458-5 · Cited by 23
Rasmussen Syndrome and Other Inflammatory Epilepsies
Varadkar, S., & Cross, J. H. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552921 · Cited by 20
Bouwkamp, C. G., Kievit, A. J. A., Markx, S., Friedman, J. I., van Zutven, L. J. C. M., van Minkelen, R., Vrijenhoek, T., Xu, B., Sterrenburg-v.d.Nieuwegiessen, I. M., Veltman, J. A., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16080946 · Cited by 20
“CNTNAP2 encodes contactinassociated protein-like 2, which regulates neuronal-glial interactions and neural cell migration (54, 55).”
BackgroundConant, A., Curiel, J., Pizzino, A. M., Sabetrasekh, P., Murphy, J. L., Bloom, M. D., Evans, S. H., Helman, G., Taft, R. J., Simons, C., et al. (2018) · Journal of Child Neurology · doi:10.1177/0883073818776157 · Cited by 20
“It should be noted that epilepsy is a well-recognized phenotype in CNTNAP2 mutations.(31,35,37) Recently, autoantibodies to Caspr2 were hypothesized to result in an autoimmune encephalitis with seizures.”
Zhang, T., Zhang, J., Wang, Z., Jia, M., Lu, T., Wang, H., Yue, W., Zhang, D., Li, J., & Wang, L. (2019) · Autism Research · doi:10.1002/aur.2078 · Cited by 21
“…Research, Wiley Periodicals, Inc. INSAR Autism Research 12: 553–561, 2019 553 was involved in dendrite stabilization, neuron migration, subsequent laminar organization, and connectivity of specific neural circuits [Gao et al., 2018; Poliak et al., 2003; Strauss et al., 2006; Zerbi et al., 2018].”
BackgroundKelleher, E., Barry, H., Cotter, D., Corvin, A. P., & Murphy, K. C. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_90 · Cited by 20
Partial Trisomy of 7q: Case Report and Literature Review
Scelsa, B., Bedeschi, F., Guerneri, S., Lalatta, F., & Introvini, P. (2007) · Journal of Child Neurology · doi:10.1177/0883073807309776 · Cited by 20
“However, this gene appears to be involved only in the latter phases of cortical histogenesis, and the MRI shows areas of cortical thickening rather then periventricular heterotopia.(21) Bilateral heterotopia has been reported in 1 case of Williams syndrome with an unusual deletion (beyond the telomeric end of the typi…”
BackgroundInfluentialCrowgey, E. L., Washburn, M. C., Kolb, E. A., & Puffenberger, E. G. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.03.004 · Cited by 20
Self-citationIdentifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays
Soreq, L., Gilboa-Geffen, A., Berrih‐Aknin, S., Lacoste, P., Darvasi, A., Soreq, E., Bergman, H., & Soreq, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002392 · Cited by 20
“5% of chromosome 7, and which functions in the vertebrate nervous system as both a cell adhesion and a receptor molecule [77] was increased as well.”
BackgroundSignaling Pathways and Sex Differential Processes in Autism Spectrum Disorder
Enriquez, K., Gupta, A. R., & Hoffman, E. J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.716673 · Cited by 22
“CNTNAP2, which encodes a cell adhesion molecule in the neurexin family, was first identified as a risk gene by a linkage study in consanguineous families from the Old Order Amish population with cortical dysplasia focal epilepsy syndrome (73).”
BackgroundChen, A. N., & Meliza, C. D. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2137-19.2019 · Cited by 21
Scott, K. E., Mann, R. S., Schormans, A. L., Schmid, S., & Allman, B. L. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhab517 · Cited by 20
“A homozygous loss of function in CNTNAP2 causes cortical dysplasia, seizures, language impairment, and autistic features (Strauss et al. 2006; Rodenas-Cuadrado et al. 2016) with various heterozygous mutations leading to less severe phenotypes, typically including an impairment in speech and…”
Chbili, C., B’chir, F., Fredj, M. B., Saguem, B. N., Amor, S. B., Ammou, S. B., & Saguem, S. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.05.009 · Cited by 19
Progress in Cytogenetics: Implications for Child Psychopathology
Hoffman, E. J., & State, M. W. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.03.016 · Cited by 20
Genetics update: Monogenetics, polygene disorders and the quest for modifying genes
Symonds, J. D., & Zuberi, S. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.013 · Cited by 20
“Pathogenic mutations in CNTN2(Stogmann et al. 2013) and CNTNAP2(Strauss et al. 2006), which encode contactin associated protein 2 (CASPR2) have been shown to disrupt clustering of potassium channels at the nodes of Ranvier in myelinated axons(Poliak et al. 2003, Peñagarikano et al. 2012) and cause a childhood- onset e…”
BackgroundGenomics of speech and language disorders
Guerra, J., & Cacabelos, R. (2019) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2018.03 · Cited by 20
Tordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 22
Contactin‐associated protein (Caspr) 2 interacts with carboxypeptidase E in the CNS
Oiso, S., Takeda, Y., Futagawa, T., Miura, T., Kuchiiwa, S., Nishida, K., Ikeda, R., Kariyazono, H., Watanabe, K., & Yamada, K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05928.x · Cited by 19
Townsend, L. B., & Smith, S. L. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9182-5 · Cited by 19
“67% of cases [11], while heterozygous mutations are associated with altered brain structure and functional connectivity in otherwise neurotypical subjects [12–14].”
BackgroundModelling monogenic autism spectrum disorder using mouse cortical organoids
Hali, S., Kim, J., Kwak, T. H., Lee, H., Shin, C. Y., & Han, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.097 · Cited by 19
Convergent synaptic and circuit substrates underlying autism genetic risks
McGee, A. W., Li, G., Lu, Z., & Qiu, S. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1298-y · Cited by 17
“For example, a rare recessive mutation in CNTNAP2 results in a syndromic form of ASD termed cortical dysplasia-focal epilepsy syndrome (Strauss et al., 2006).”
BackgroundShiota, Y., Hirosawa, T., Yoshimura, Y., Tanaka, S., Hasegawa, C., Iwasaki, S., An, K., Soma, D., Sano, M., Yokoyama, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260548 · Cited by 17
“Originally, a recessive nonsense mutation in CNTNAP2 was observed to cause cortical dysplasia focal epilepsy syndrome, a syndromic form of ASD [14].”
BackgroundKember, R. L., Georgi, B., Wilson, J., Stambolian, D., Paul, S. M., & Bućan, M. (2015) · BMC Genetics · doi:10.1186/s12863-015-0184-1 · Cited by 22
Functional Evaluations of Genes Disrupted in Patients with Tourette’s Disorder
Sun, N., Tischfield, J. A., King, R. A., & Heiman, G. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00011 · Cited by 17
Malformations of Cortical Development
Dobyns, W. B., Guerrini, R., & Leventer, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00026-3 · Cited by 17
A Songbird Animal Model for Dissecting the Genetic Bases of Autism Spectrum Disorder
Panaitof, S. C. (2012) · Disease Markers · doi:10.1155/2012/727058 · Cited by 21
Pharmacology and Genetics of Autism: Implications for Diagnosis and Treatment
Brkanac, Z., Raskind, W. H., & King, B. H. (2008) · Personalized Medicine · doi:10.2217/17410541.5.6.599 · Cited by 20
BADSHAH, N., Mattison, K. A., Ahmad, S., Chopra, P., Johnston, H. R., Ahmad, S., Khan, S. H., Sarwar, M. T., Cutler, D. J., Taylor, M., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.918022 · Cited by 17
“Prior to the current study, all reported disease-associated CNTNAP2 variants were homozygous or biallelic deletions, splice site variants or nonsense variants which would be predicted to abolish protein function (14, 16, 37, 40).”
BackgroundNodes of Ranvier in health and disease
Eshed‐Eisenbach, Y., Brophy, P., & Peles, E. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12568 · Cited by 22
Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
Ahmad, S. R., Zeyaullah, M., AlShahrani, A. M., Dawria, A., Ali, H., Mohieldin, A., Altijani, A. A. G., Razi, U., Mehdi, M., Akram, S., et al. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904142 · Cited by 15
Piluso, G., Monteleone, P., Galderisi, S., Giugliano, T., Bertolino, A., Rocca, P., Rossi, A., Mucci, A., Aguglia, E., Andriola, I., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1395072 · Cited by 17
“Mutations in CNTNAP2 have already been described in members of Old Order Amish families presenting a neuropathological phenotype with cortical dysplasia and focal epilepsy, as well as in two other unrelated families with Pitt-Hopkinslike syndrome (Strauss et al. 2006; Wurst and Prakash, 2014).”
BackgroundZheng, A., Scott, K. E., Schormans, A. L., Mann, R. S., Allman, B. L., & Schmid, S. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.01.020 · Cited by 16
Talpo, F., Spaiardi, P., Castagno, A. N., Maniezzi, C., Raffin, F., Terribile, G., Sancini, G., Pisani, A., & Biella, G. R. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1082010 · Cited by 15
“Mutations in the contactin-associated protein-like 2 (CNTNAP2) are implicated in cortical dysplasia-focal epilepsy syndrome, epilepsy, attention-deficit hyperactivity disorder and autism spectrum disorders (Strauss et al., 2006; Elia et al., 2010; Mefford et al., 2010; Rodenas-Cuadrado et al., 2014).”
Background
Metadata
- Authors
- Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H.
- Affiliations
- Clinic for Special Children (US)
- Translational Genomics Research Institute (US)
- Lancaster General Hospital (US)
- Marshfield Clinic Research Foundation (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-03-30
- Volume
- 354
- Issue
- 13
- Pages
- 1370-1377
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022498096
- Cited by
- 630
- References
- 24
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 17 · 2023: 28 · 2022: 24 · 2021: 25 · 2020: 29 · 2019: 31 · 2018: 37 · 2017: 47 · 2016: 33 · 2015: 45 · 2014: 29 · 2013: 43 · 2012: 47
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- CNTNAP2, nodes of Ranvier, cortical dysplasia, macrocephaly, language regression, intellectual disability, seizure recurrence, resective surgery, astrocyte activation, Old Order Amish
- MeSH terms
- Child, Child, Preschool, Electroencephalography, Epilepsies, Partial, Homozygote, Humans, Membrane Proteins, Mutation, Nerve Tissue Proteins, Phenotype, Reflex, Stretch, Seizures, Temporal Lobe, Gene Expression, Magnetic Resonance Angiography, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.